Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1597748154;48155;48156 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
N2AB1433643231;43232;43233 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
N2A1340940450;40451;40452 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
N2B691220959;20960;20961 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
Novex-1703721334;21335;21336 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
Novex-2710421535;21536;21537 chr2:178616960;178616959;178616958chr2:179481687;179481686;179481685
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCA
  • RefSeq wild type template codon: GGT
  • Domain: Ig-109
  • Domain position: 10
  • Structural Position: 24
  • Q(SASA): 0.3936
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/S None None 1.0 N 0.729 0.368 0.258779203287 gnomAD-4.0.0 1.59343E-06 None None None None I None 0 0 None 0 2.7784E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.5663 likely_pathogenic 0.5517 ambiguous -0.683 Destabilizing 1.0 D 0.677 prob.neutral N 0.444868925 None None I
P/C 0.945 likely_pathogenic 0.9447 pathogenic -0.661 Destabilizing 1.0 D 0.727 prob.delet. None None None None I
P/D 0.8219 likely_pathogenic 0.8247 pathogenic -0.523 Destabilizing 1.0 D 0.699 prob.neutral None None None None I
P/E 0.7788 likely_pathogenic 0.7586 pathogenic -0.637 Destabilizing 1.0 D 0.711 prob.delet. None None None None I
P/F 0.9864 likely_pathogenic 0.9841 pathogenic -0.844 Destabilizing 1.0 D 0.712 prob.delet. None None None None I
P/G 0.5538 ambiguous 0.5582 ambiguous -0.831 Destabilizing 1.0 D 0.745 deleterious None None None None I
P/H 0.8416 likely_pathogenic 0.8295 pathogenic -0.342 Destabilizing 1.0 D 0.693 prob.neutral None None None None I
P/I 0.9726 likely_pathogenic 0.9708 pathogenic -0.44 Destabilizing 1.0 D 0.761 deleterious None None None None I
P/K 0.8747 likely_pathogenic 0.8647 pathogenic -0.612 Destabilizing 1.0 D 0.701 prob.neutral None None None None I
P/L 0.8402 likely_pathogenic 0.8254 pathogenic -0.44 Destabilizing 1.0 D 0.747 deleterious N 0.499504563 None None I
P/M 0.9521 likely_pathogenic 0.9467 pathogenic -0.37 Destabilizing 1.0 D 0.694 prob.neutral None None None None I
P/N 0.8215 likely_pathogenic 0.8206 pathogenic -0.34 Destabilizing 1.0 D 0.745 deleterious None None None None I
P/Q 0.7686 likely_pathogenic 0.7473 pathogenic -0.62 Destabilizing 1.0 D 0.731 prob.delet. N 0.497625357 None None I
P/R 0.7768 likely_pathogenic 0.7589 pathogenic -0.01 Destabilizing 1.0 D 0.742 deleterious N 0.433927109 None None I
P/S 0.6402 likely_pathogenic 0.6283 pathogenic -0.706 Destabilizing 1.0 D 0.729 prob.delet. N 0.456430052 None None I
P/T 0.6691 likely_pathogenic 0.6411 pathogenic -0.724 Destabilizing 1.0 D 0.715 prob.delet. N 0.433927109 None None I
P/V 0.9301 likely_pathogenic 0.9261 pathogenic -0.486 Destabilizing 1.0 D 0.712 prob.delet. None None None None I
P/W 0.9866 likely_pathogenic 0.9843 pathogenic -0.903 Destabilizing 1.0 D 0.726 prob.delet. None None None None I
P/Y 0.9637 likely_pathogenic 0.9631 pathogenic -0.627 Destabilizing 1.0 D 0.733 prob.delet. None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.